Commodity pages confirm success ("it should be clear")
The first Complete Response Letter, in which the regulator cited manufacturing issues, came in 2017, and the FDA issued a second CRL in March 2022, flagging signals of AKI
Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers
Rare but serious events encompass provocation or exacerbation of seizures in susceptible individuals and hypersensitivity reactions ranging from urticaria to anaphylaxis
112 There were no significant between-group differences on other measures of neuropsychological function, or measures of anxiety, depression, or loneliness
None of these episodes of drop in blood pressure led to death or long-term problems for the patients, however, and the blood pressure returned to baseline in these cases